These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 29259518)

  • 1. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
    Rasoulinejad SA; Maroufi F
    Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 genome surgery for retinal diseases.
    Xu CL; Park KS; Tsang SH
    Drug Discov Today Technol; 2018 Aug; 28():23-32. PubMed ID: 30205877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
    Lin WV; Stout JT; Weng CY
    Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
    [No Abstract]   [Full Text] [Related]  

  • 6. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
    Peddle CF; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Let There Be Light: Gene and Cell Therapy for Blindness.
    Dalkara D; Goureau O; Marazova K; Sahel JA
    Hum Gene Ther; 2016 Feb; 27(2):134-47. PubMed ID: 26751519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application and progression of CRISPR/Cas9 technology in ophthalmological diseases.
    Hu X; Zhang B; Li X; Li M; Wang Y; Dan H; Zhou J; Wei Y; Ge K; Li P; Song Z
    Eye (Lond); 2023 Mar; 37(4):607-617. PubMed ID: 35915232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease.
    Zaneveld J; Wang F; Wang X; Chen R
    Sci China Life Sci; 2013 Feb; 56(2):125-33. PubMed ID: 23393028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa.
    Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L
    Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy and genome surgery in the retina.
    DiCarlo JE; Mahajan VB; Tsang SH
    J Clin Invest; 2018 Jun; 128(6):2177-2188. PubMed ID: 29856367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases.
    Chuang K; Fields MA; Del Priore LV
    Yale J Biol Med; 2017 Dec; 90(4):635-642. PubMed ID: 29259527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR genome engineering for retinal diseases.
    Kantor A; McClements ME; Peddle CF; Fry LE; Salman A; Cehajic-Kapetanovic J; Xue K; MacLaren RE
    Prog Mol Biol Transl Sci; 2021; 182():29-79. PubMed ID: 34175046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.
    Cai B; Sun S; Li Z; Zhang X; Ke Y; Yang J; Li X
    Hum Genet; 2018 Sep; 137(9):679-688. PubMed ID: 30203114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR in the Retina: Evaluation of Future Potential.
    Cho GY; Justus S; Sengillo JD; Tsang SH
    Adv Exp Med Biol; 2017; 1016():147-155. PubMed ID: 29130158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Editing Strategies for Treating Human Retinal Degenerations.
    Quinn J; Musa A; Kantor A; McClements ME; Cehajic-Kapetanovic J; MacLaren RE; Xue K
    Hum Gene Ther; 2021 Mar; 32(5-6):247-259. PubMed ID: 32993386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing in Retinal Diseases using CRISPR Technology.
    Yiu G
    Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
    [No Abstract]   [Full Text] [Related]  

  • 20. With First CRISPR Trials, Gene Editing Moves Toward the Clinic.
    Hampton T
    JAMA; 2020 Apr; 323(16):1537-1539. PubMed ID: 32267478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.